• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性大麻素系统在胰岛中的功能及其对代谢综合征和糖尿病的影响。

The function of the endocannabinoid system in the pancreatic islet and its implications on metabolic syndrome and diabetes.

机构信息

Posgrado e Investigación, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional Mexico City Mexico.

Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Coyoacán, Mexico.

出版信息

Islets. 2023 Dec 31;15(1):1-11. doi: 10.1080/19382014.2022.2163826.

DOI:10.1080/19382014.2022.2163826
PMID:36598083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9815253/
Abstract

The following review focuses on the scientific studies related to the role of endocannabinoid system (ECS) in pancreatic islet physiology and dysfunction. Different natural or synthetic agonists and antagonists have been suggested as an alternative treatment for diabetes, obesity and metabolic syndrome. Therapeutic use of led to the discovery and characterization of the ECS, a signaling complex involved in regulation of various physiological processes, including food intake and metabolism. After the development of different agonists and antagonists, evidence have demonstrated the presence and activity of cannabinoid receptors in several organs and tissues, including pancreatic islets. Insulin and glucagon expression, stimulated secretion, and the development of diabetes and other metabolic disorders have been associated with the activity and modulation of ECS in pancreatic islets. However, according to the animal model and experimental design, either endogenous or pharmacological ligands of cannabinoid receptors have guided to contradictory and paradoxical results that suggest a complex physiological interaction. In consensus, ECS activity modulates insulin and glucagon secretions according to glucose in media; over-stimulation of cannabinoid receptors affects islets negatively, leading to glucose intolerance, meanwhile the treatment with antagonists in diabetic models and humans suggests an improvement in islets function.

摘要

以下综述重点介绍了内源性大麻素系统(ECS)在胰岛生理学和功能障碍中的作用的相关科学研究。不同的天然或合成激动剂和拮抗剂已被提议作为糖尿病、肥胖症和代谢综合征的替代治疗方法。对大麻素的治疗用途的研究导致了 ECS 的发现和特征描述,ECS 是一种参与调节包括食物摄入和代谢在内的各种生理过程的信号复合物。在开发出不同的激动剂和拮抗剂之后,有证据表明大麻素受体存在于包括胰岛在内的多种器官和组织中。胰岛素和胰高血糖素的表达、受刺激的分泌以及糖尿病和其他代谢紊乱的发展都与胰岛中 ECS 的活性和调节有关。然而,根据动物模型和实验设计,内源性或药理学的大麻素受体配体引导出相互矛盾和自相矛盾的结果,表明存在复杂的生理相互作用。总的来说,根据培养基中的葡萄糖,ECS 活性调节胰岛素和胰高血糖素的分泌;大麻素受体的过度刺激会对胰岛产生负面影响,导致葡萄糖不耐受,而在糖尿病模型和人类中使用拮抗剂的治疗表明胰岛功能得到改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/9815253/a591c10020a8/KISL_A_2163826_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/9815253/c532e223c1ed/KISL_A_2163826_UF0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/9815253/9b7a02480eaf/KISL_A_2163826_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/9815253/2742e8c0e433/KISL_A_2163826_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/9815253/a591c10020a8/KISL_A_2163826_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/9815253/c532e223c1ed/KISL_A_2163826_UF0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/9815253/9b7a02480eaf/KISL_A_2163826_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/9815253/2742e8c0e433/KISL_A_2163826_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0da7/9815253/a591c10020a8/KISL_A_2163826_F0003_OC.jpg

相似文献

1
The function of the endocannabinoid system in the pancreatic islet and its implications on metabolic syndrome and diabetes.内源性大麻素系统在胰岛中的功能及其对代谢综合征和糖尿病的影响。
Islets. 2023 Dec 31;15(1):1-11. doi: 10.1080/19382014.2022.2163826.
2
Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function.在体外慢性激活大麻素受体不会损害小鼠胰岛功能。
Clin Sci (Lond). 2013 Apr;124(7):467-78. doi: 10.1042/CS20120447.
3
An Autonomous Cannabinoid System in Islets of Langerhans.胰岛中的自主大麻素系统。
Front Endocrinol (Lausanne). 2021 Jul 5;12:699661. doi: 10.3389/fendo.2021.699661. eCollection 2021.
4
Expression and function of cannabinoid receptors in mouse islets.大麻素受体在小鼠胰岛中的表达和功能。
Islets. 2010 Sep-Oct;2(5):293-302. doi: 10.4161/isl.2.5.12729. Epub 2010 Sep 1.
5
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans.大麻素对大鼠胰岛分离物胰岛素分泌的复杂影响。
Eur J Pharmacol. 2013 Apr 15;706(1-3):56-62. doi: 10.1016/j.ejphar.2013.02.034. Epub 2013 Mar 13.
6
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.使用克隆β细胞、分离的胰岛和小鼠评估GPR55脂质激动剂的胰岛素释放和抗高血糖活性。
Br J Pharmacol. 2013 Nov;170(5):978-90. doi: 10.1111/bph.12356.
7
Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.正常大鼠和糖尿病大鼠胰岛组织中的葡萄糖和三磷酸腺苷水平。
J Clin Invest. 1976 Nov;58(5):1193-200. doi: 10.1172/JCI108572.
8
Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.植物源天然治疗剂靶向代谢综合征及其并发症中的大麻素受体:综述。
Biomed Pharmacother. 2020 Dec;132:110889. doi: 10.1016/j.biopha.2020.110889. Epub 2020 Oct 28.
9
The role of the pancreatic endocannabinoid system in glucose metabolism.胰腺内源性大麻素系统在葡萄糖代谢中的作用。
Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):87-102. doi: 10.1016/j.beem.2008.10.012.
10
Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon.褪黑素与胰岛:褪黑素、胰岛素和胰高血糖素之间的相互关系。
Int J Mol Sci. 2013 Mar 27;14(4):6981-7015. doi: 10.3390/ijms14046981.

引用本文的文献

1
Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management.植物大麻素作为新型SGLT2调节剂用于2型糖尿病管理中的肾脏葡萄糖重吸收
Pharmaceuticals (Basel). 2025 Jul 24;18(8):1101. doi: 10.3390/ph18081101.
2
Shared and unique 3D genomic features of substance use disorders across multiple cell types.多种细胞类型中物质使用障碍的共享和独特三维基因组特征。
medRxiv. 2024 Jul 19:2024.07.18.24310649. doi: 10.1101/2024.07.18.24310649.
3
Antidiabetic Effect of Standardized Hydroethanolic Extract by Targeting α-Glucosidase and the PTP-1B Signaling Pathway for Alleviating Diabetes in Experimental Model.

本文引用的文献

1
Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control.市售可食用大麻产品在人体中的药代动力学研究:身体成分的潜在影响及对血糖控制的影响
Pharmaceuticals (Basel). 2021 Aug 20;14(8):817. doi: 10.3390/ph14080817.
2
Cannabinoids Drugs and Oral Health-From Recreational Side-Effects to Medicinal Purposes: A Systematic Review.大麻素类药物与口腔健康——从娱乐性副作用到药用目的:系统评价。
Int J Mol Sci. 2021 Aug 3;22(15):8329. doi: 10.3390/ijms22158329.
3
Novel CB1 receptor antagonist BAR-1 modifies pancreatic islet function and clinical parameters in prediabetic and diabetic mice.
标准化水乙醇提取物通过靶向α-葡萄糖苷酶和蛋白酪氨酸磷酸酶-1B信号通路对实验模型糖尿病的抗糖尿病作用
J Pharmacopuncture. 2023 Dec 31;26(4):319-326. doi: 10.3831/KPI.2023.26.4.319.
4
Effect of cannabis and subproducts on anthropometric measures: a systematic review and meta-analysis.大麻及其副产物对人体测量学指标的影响:系统评价和荟萃分析。
Int J Obes (Lond). 2024 Jan;48(1):44-54. doi: 10.1038/s41366-023-01399-x. Epub 2023 Nov 7.
5
Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity.探索大麻素受体拮抗剂在炎症、糖尿病和肥胖症中的治疗潜力。
Biomedicines. 2023 Jun 8;11(6):1667. doi: 10.3390/biomedicines11061667.
新型 CB1 受体拮抗剂 BAR-1 可改善糖尿病前期和糖尿病小鼠的胰岛功能和临床参数。
Nutr Diabetes. 2020 Mar 4;10(1):7. doi: 10.1038/s41387-020-0110-0.
4
The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling.大麻素配体 SR141716A 和 AM251 通过非 GPR55 依赖性信号增强人源和鼠源胰岛功能。
Cell Mol Life Sci. 2020 Nov;77(22):4709-4723. doi: 10.1007/s00018-019-03433-6. Epub 2020 Jan 10.
5
New approaches and challenges to targeting the endocannabinoid system.靶向内源性大麻素系统的新方法与挑战
Nat Rev Drug Discov. 2018 Sep;17(9):623-639. doi: 10.1038/nrd.2018.115. Epub 2018 Aug 17.
6
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain.2-花生四烯酸甘油酯:一种在大脑中具有多种作用的信号脂质。
Prog Lipid Res. 2018 Jul;71:1-17. doi: 10.1016/j.plipres.2018.05.002. Epub 2018 May 8.
7
Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets.β细胞中缺乏大麻素 1 受体可防止高脂肪/高糖饮食诱导的胰岛β细胞功能障碍和炎症。
Diabetologia. 2018 Jun;61(6):1470-1483. doi: 10.1007/s00125-018-4576-4. Epub 2018 Mar 1.
8
Blockade of cannabinoid 1 receptor improves glucose responsiveness in pancreatic beta cells.阻断大麻素 1 受体可改善胰岛β细胞的葡萄糖反应性。
J Cell Mol Med. 2018 Apr;22(4):2337-2345. doi: 10.1111/jcmm.13523. Epub 2018 Feb 12.
9
LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling.LH-21 和异常大麻素通过 GPR55 依赖和非依赖信号通路改善分离的人源和鼠源胰岛β细胞功能。
Diabetes Obes Metab. 2018 Apr;20(4):930-942. doi: 10.1111/dom.13180. Epub 2018 Jan 10.
10
Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.大麻素2型受体激动剂改善高脂饮食/链脲佐菌素诱导的糖尿病小鼠的全身胰岛素敏感性。
Cell Physiol Biochem. 2016;40(5):1175-1185. doi: 10.1159/000453171. Epub 2016 Dec 14.